Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Betacellulin inhibits osteogenic differentiation and stimulates proliferation through HIF-1alpha.

Genetos DC, Rao RR, Vidal MA.

Cell Tissue Res. 2010 Apr;340(1):81-9. doi: 10.1007/s00441-010-0929-0. Epub 2010 Feb 18.

2.

Tyrphostin ErbB2 Inhibitors AG825 and AG879 Have Non-specific Suppressive Effects on gp130/ STAT3 Signaling.

Lee HK, Seo IA, Lee SH, Seo SY, Kim KS, Park HT.

Korean J Physiol Pharmacol. 2008 Oct;12(5):281-6. doi: 10.4196/kjpp.2008.12.5.281. Epub 2008 Oct 31.

3.

Current advances and travails in islet transplantation.

Harlan DM, Kenyon NS, Korsgren O, Roep BO; Immunology of Diabetes Society.

Diabetes. 2009 Oct;58(10):2175-84. doi: 10.2337/db09-0476. Review. No abstract available.

4.

Specific transgene expression in mouse pancreatic beta-cells under the control of the porcine insulin promoter.

Grzech M, Dahlhoff M, Herbach N, Habermann FA, Renner-Müller I, Wanke R, Flaswinkel H, Wolf E, Schneider MR.

Mol Cell Endocrinol. 2010 Feb 5;315(1-2):219-24. doi: 10.1016/j.mce.2009.08.001. Epub 2009 Aug 12.

PMID:
19682540
5.

Generation of insulin-secreting cells from adult rat pancreatic ductal epithelial cells induced by hepatocyte growth factor and betacellulin-delta4.

Zhan XR, Li XY, Liu XM, Zhou JH, Yang YL, Yi R, Zhang J, Yang BF.

Biochem Biophys Res Commun. 2009 May 1;382(2):375-80. doi: 10.1016/j.bbrc.2009.03.029. Epub 2009 Mar 11.

PMID:
19285040
6.

Betacellulin overexpression in transgenic mice improves glucose tolerance and enhances insulin secretion by isolated islets in vitro.

Dahlhoff M, Dames PM, Lechner A, Herbach N, van Bürck L, Wanke R, Wolf E, Schneider MR.

Mol Cell Endocrinol. 2009 Feb 27;299(2):188-93. doi: 10.1016/j.mce.2008.11.022. Epub 2008 Nov 28.

PMID:
19100309
7.

A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability.

Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K.

Talanta. 1997 Jul;44(7):1299-305.

PMID:
18966866
8.

A betacellulin mutant promotes differentiation of pancreatic acinar AR42J cells into insulin-producing cells with low affinity of binding to ErbB1.

Nagaoka T, Fukuda T, Hashizume T, Nishiyama T, Tada H, Yamada H, Salomon DS, Yamada S, Kojima I, Seno M.

J Mol Biol. 2008 Jun 27;380(1):83-94. doi: 10.1016/j.jmb.2008.03.054. Epub 2008 Apr 3.

PMID:
18508082
9.

Remission of diabetes by beta-cell regeneration in diabetic mice treated with a recombinant adenovirus expressing betacellulin.

Shin S, Li N, Kobayashi N, Yoon JW, Jun HS.

Mol Ther. 2008 May;16(5):854-61. doi: 10.1038/mt.2008.22. Epub 2008 Mar 18. Erratum in: Mol Ther. 2008 Jul;16(7):1347.

10.

Epidermal growth factor increases insulin secretion and lowers blood glucose in diabetic mice.

Lee HY, Yea K, Kim J, Lee BD, Chae YC, Kim HS, Lee DW, Kim SH, Cho JH, Jin CJ, Koh DS, Park KS, Suh PG, Ryu SH.

J Cell Mol Med. 2008 Sep-Oct;12(5A):1593-604. Epub 2007 Dec 5.

11.

Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the anti-apoptotic action of growth factors in human islets.

Sarkar SA, Gunter J, Bouchard R, Reusch JE, Wiseman A, Gill RG, Hutton JC, Pugazhenthi S.

Diabetologia. 2007 Aug;50(8):1649-59. Epub 2007 Jun 26.

PMID:
17593347
12.
13.

Neogenesis and proliferation of beta-cells induced by human betacellulin gene transduction via retrograde pancreatic duct injection of an adenovirus vector.

Tokui Y, Kozawa J, Yamagata K, Zhang J, Ohmoto H, Tochino Y, Okita K, Iwahashi H, Namba M, Shimomura I, Miyagawa J.

Biochem Biophys Res Commun. 2006 Dec 1;350(4):987-93. Epub 2006 Oct 6.

PMID:
17046717
14.

EGF-ERBB signalling: towards the systems level.

Citri A, Yarden Y.

Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16. Review.

PMID:
16829981
15.

Effect of epiregulin on pancreatic beta cell growth and insulin secretion.

Kuntz E, Broca C, Komurasaki T, Kaltenbacher MC, Gross R, Pinget M, Damgé C.

Growth Factors. 2005 Dec;23(4):285-93.

PMID:
16338791
16.

New sources of pancreatic beta-cells.

Bonner-Weir S, Weir GC.

Nat Biotechnol. 2005 Jul;23(7):857-61. Review.

PMID:
16003374
17.

Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass.

Suarez-Pinzon WL, Lakey JR, Brand SJ, Rabinovitch A.

J Clin Endocrinol Metab. 2005 Jun;90(6):3401-9. Epub 2005 Mar 15.

PMID:
15769977
18.

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.

Johns TG, Luwor RB, Murone C, Walker F, Weinstock J, Vitali AA, Perera RM, Jungbluth AA, Stockert E, Old LJ, Nice EC, Burgess AW, Scott AM.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15871-6. Epub 2003 Dec 15.

19.

Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes.

Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, Zakaria M, Mossa-Basha M, White MF.

J Clin Invest. 2003 Nov;112(10):1521-32.

20.

Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.

Shin HS, Lee HJ, Nishida M, Lee MS, Tamura R, Yamashita S, Matsuzawa Y, Lee IK, Koh GY.

Circ Res. 2003 Aug 22;93(4):302-10. Epub 2003 Jul 17.

Supplemental Content

Support Center